We are live on ! Find out more
VC

Voss Capital Portfolio holdings

AUM $2.15B
1-Year Est. Return 33.46%
This Fund
S&P 500
This Quarter Est. Return
+7.99%
1 Year Est. Return
+33.46%
3 Year Est. Return
+78.4%
5 Year Est. Return
+196.08%
10 Year Est. Return
AUM
$2.03B
AUM Growth
+$578M
Cap. Flow
+$224M
Cap. Flow %
11.04%
Top 10 Hldgs %
61.4%
Holding
67
New
13
Increased
23
Reduced
16
Closed
9

Top Buys

Rank Stock Value
1
PAR icon
PAR Technology
PAR
+$69.9M
2
AVTR icon
Avantor
AVTR
+$52.5M
3
EEFT icon
Euronet Worldwide
EEFT
+$51.3M
4
KNF icon
Knife River
KNF
+$35.9M
5
FIVN icon
FIVE9
FIVN
+$34.4M

Top Sells

Rank Stock Value
1
CRH icon
CRH
CRH
+$37M
2
PHIN icon
Phinia Inc
PHIN
+$32.9M
3
AMTM
Amentum Holdings
AMTM
+$18.9M
4
SWIM icon
Latham Group
SWIM
+$14.3M
5
MHO icon
M/I Homes
MHO
+$14M

Sector Composition

Rank Sector Weight
1 Technology 31.99%
2 Consumer Discretionary 20.25%
3 Industrials 16.66%
4 Miscellaneous 14.3%
5 Healthcare 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IRD
51
Opus Genetics
IRD
$484M
$928K 0.05%
562,377
+21,218
+4% +$26.4K
FLYW icon
52
CALL
Flywire
FLYW
$2.16B
$677K 0.03%
+50,000
New +$615K
CGTX icon
53
Cognition Therapeutics
CGTX
$97.9M
$405K 0.02%
300,000
-150,000
-33% -$205K
PAR icon
54
CALL
PAR Technology
PAR
$699M
$368K 0.02%
+9,300
New +$514K
RCL icon
55
PUT
Royal Caribbean
RCL
$66.7B
$324K 0.02%
+1,000
New +$334K
EOLS icon
56
CALL
Evolus
EOLS
$522M
$307K 0.02%
+50,000
New +$390K
LTRN icon
57
Lantern Pharma
LTRN
$21.7M
$218K 0.01%
50,000
CLBT icon
58
PUT
Cellebrite
CLBT
$2.83B
$42.6K ﹤0.01%
+2,300
New +$36.1K
BLD
59
DELISTED
TopBuild
BLD
-10,000
Closed -$3.24M
BLDR icon
60
Builders FirstSource
BLDR
$6.48B
-35,000
Closed -$4.08M
BZH icon
61
Beazer Homes USA
BZH
$890M
-25,768
Closed -$576K
DHI icon
62
D.R. Horton
DHI
$39.2B
-30,000
Closed -$3.87M
ECVT icon
63
Ecovyst
ECVT
$1.15B
-641,317
Closed -$5.28M
EXTR icon
64
Extreme Networks
EXTR
$2.88B
-250,000
Closed -$4.49M
MHO icon
65
M/I Homes
MHO
$3.6B
-125,000
Closed -$14M
NATH icon
66
Nathan's Famous
NATH
$400M
-5,800
Closed -$641K
XERS icon
67
Xeris Biopharma Holdings
XERS
$1.37B
-319,800
Closed -$1.49M

Similar funds

Voss Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Voss Capital held 67 positions worth $2.03B, up 40% from $1.45B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Voss Capital deployed $224M of net new capital in Q3 2025, opening 13 new positions and adding to 23 existing holdings. Its largest new stake was Knife River: 440,000 shares worth $33.8M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was CRH, an estimated $37M trimmed.

  • Voss Capital's largest Q3 2025 buy was Knife River: 440,000 shares worth $33.8M.
  • Voss Capital added most to PAR Technology in Q3 2025, an estimated $69.9M increase.
  • Voss Capital's biggest Q3 2025 reduction was CRH, cutting an estimated $37M.
  • Voss Capital fully exited M/I Homes in Q3 2025, selling an estimated $14M.
  • Voss Capital's ten largest holdings make up 61% of its $2.03B portfolio in Q3 2025.
  • Voss Capital opened 13 new positions and closed 9 in Q3 2025.
  • Voss Capital's portfolio value rose 40% quarter-over-quarter to $2.03B.

Based on Voss Capital's 13F filing for Q3 2025, filed 13 Nov 2025.